...
首页> 外文期刊>HPB: the official journal of the International Hepato Pancreato Biliary Association >The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma
【24h】

The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma

机译:门静脉和肝动脉涉及患者患者胆管性胆管癌的预后价值

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background Although several classifications of perihilar cholangiocarcinoma (PHC) include vascular involvement, its prognostic value has not been investigated. Our aim was to assess the prognostic value of unilateral and main/bilateral involvement of the portal vein (PV) and hepatic artery (HA) on imaging in patients with PHC. Methods All patients with PHC between 2002 and 2014 were included regardless of stage or management. Vascular involvement was defined as apparent tumor contact of at least 180° to the PV or HA on imaging. Kaplan–Meier method with log-rank test was used to compare overall survival (OS) between groups. Cox regression was used for multivariable analysis. Results In total, 674 patients were included with a median OS of 12.2 (95% CI 10.6–13.7) months. Patients with unilateral PV involvement had a median OS of 13.3 (11.0–15.7) months, compared with 14.7 (11.7–17.6) in patients without PV involvement ( p ?=?0.12). Patients with main/bilateral PV involvement had an inferior median OS of 8.0 (5.4–10.7, p ? Median OS for patients with unilateral HA involvement was 10.6 (9.3–12.0) months compared with 16.9 (13.2–20.5) in patients without HA involvement ( p ? p ? Conclusion Both unilateral and main HA involvement are independent poor prognostic factors for OS in patients presenting with PHC, whereas PV involvement is not.
机译:摘要背景虽然有几种Periwill胆管癌(PHC)的分类包括血管受累,但其预后价值尚未被调查。我们的目的是评估门静脉(PV)和肝动脉(HA)对PHC患者的成像的单侧和主要/双侧参与的预后价值。方法,无论阶段或管理如何,所有患有2002和2014之间的PHC患者。血管受累定义为在成像上的PV或HA至少180°的表观肿瘤接触。使用Log-Rank测试的Kaplan-Meier方法用于比较组之间的整体生存(OS)。 COX回归用于多变量分析。结果总计,674名患者包含12.2(95%CI 10.6-13.7)的中位数。单侧PV患者的患者有13.3(11.0-15.7)个月的中位数,而没有PV参与的患者(P?= 0.12)。具有主要/双侧PV参与的患者的8.0次(5.4-10.7,P≤ysylylalaha患者中位操作系统,与16.9(13.2-20.5)相比,没有HA参与的患者(13.2-20.5) (P?P?结论单侧和主要的HA参与都是患有PHC患者的OS的独立差的预后因素,而PV参与则不是。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号